365 related articles for article (PubMed ID: 35323676)
1. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.
Candelise N; Salvatori I; Scaricamazza S; Nesci V; Zenuni H; Ferri A; Valle C
Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323676
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
Belosludtseva NV; Matveeva LA; Belosludtsev KN
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069154
[TBL] [Abstract][Full Text] [Related]
3. Progressive Mitochondrial SOD1
Méndez-López I; Sancho-Bielsa FJ; Engel T; García AG; Padín JF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360957
[TBL] [Abstract][Full Text] [Related]
4. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.
Benson BC; Shaw PJ; Azzouz M; Highley JR; Hautbergue GM
Front Neurosci; 2021; 15():783624. PubMed ID: 35002606
[TBL] [Abstract][Full Text] [Related]
5. The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.
Loeffler JP; Picchiarelli G; Dupuis L; Gonzalez De Aguilar JL
Brain Pathol; 2016 Mar; 26(2):227-36. PubMed ID: 26780251
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
Manfredi G; Xu Z
Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
[TBL] [Abstract][Full Text] [Related]
10. Glial Metabolic Reprogramming in Amyotrophic Lateral Sclerosis.
Cassina P; Miquel E; Martínez-Palma L; Cassina A
Neuroimmunomodulation; 2021; 28(4):204-212. PubMed ID: 34175843
[TBL] [Abstract][Full Text] [Related]
11. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera TW; Steyn FJ; Ngo ST; Borges K
Cell Biosci; 2021 Jan; 11(1):14. PubMed ID: 33431046
[TBL] [Abstract][Full Text] [Related]
12. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
Shi P; Gal J; Kwinter DM; Liu X; Zhu H
Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction and amyotrophic lateral sclerosis.
Hervias I; Beal MF; Manfredi G
Muscle Nerve; 2006 May; 33(5):598-608. PubMed ID: 16372325
[TBL] [Abstract][Full Text] [Related]
15. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis.
Faes L; Callewaert G
J Bioenerg Biomembr; 2011 Dec; 43(6):587-92. PubMed ID: 22072073
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Cellular Mechanisms Affected in ALS.
Le Gall L; Anakor E; Connolly O; Vijayakumar UG; Duddy WJ; Duguez S
J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32854276
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: newcomers into the ALS picture.
Volonte C; Apolloni S; Parisi C
CNS Neurol Disord Drug Targets; 2015; 14(2):194-207. PubMed ID: 25613506
[TBL] [Abstract][Full Text] [Related]
20. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
